Sarcoidosis is a chronic disease that affects multiple organs, but in 95 percent of all cases, the lungs are involved. Typically, the disease occurs when the immune system overreacts, forming small clusters of abnormal cells called granulomas.
What causes sarcoidosis?
Sarcoidosis has no known cause, but it is not contagious like respiratory viruses. It can occur in families, but there is no evidence that it’s inherited. Most people with sarcoidosis live normal lives, and it often appears and resolves on its own without treatment. However, permanent lung damage can occur in 20 to 30 percent of people with sarcoidosis, and it’s chronic and progressive in 10 to 15 percent of patients.
Since the cause is unknown, risk factors are hard to determine, but we do know that:
- The disease is slightly more likely to show up in people of African and Scandinavian descent than Caucasians and other nationalities.
- Women are more likely to develop sarcoidosis.
- Exposure to dust or mold may increase the risk of developing sarcoidosis.
- Sarcoidosis most often appears in people between 20 and 40 years old.
Cellular therapy may help treat sarcoidosis
Cellular therapy is a regenerative treatment that leverages the patient’s own cells to help encourage new lung tissue growth. Through minimally invasive treatment, the Lung Health Institute removes a small sample of blood from the patient. We enrich the sample with platelet-rich plasma to create a concentrated mixture of cells that helps to stimulate new growth and then reintroduces them to the patient’s body. Many of our patients have reported overall lung improvement and increased quality of life after receiving our cellular therapy treatment.
To learn more about cellular therapy and how it may help treat sarcoidosis by targeting the inflammation in the lungs, contact us today at 855-882-1292 and speak with a patient coordinator. We are here to help you take the next step toward finding relief from chronic lung diseases.